Industry

DUBLIN–(BUSINESS WIRE)–The “Nasal Drug Delivery Mode Market, by Therapeutic Application, by Dosage Form, by Container Type, by System Type, by End-users, by Distribution, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. Drug delivery refers to the technology utilized to present the drug to … [Read more…]

Influenza vaccine candidate OVX836 safety profile and efficacy signals from Phase 2a dose-optimization study to be presented at UIV 2022 Preclinical proof of cross-protection against SARS-COV-2 with OVX033 in hamster challenge model to be presented at Options XI Additional results on the synergy of co-administering T-cell based vaccine candidate OVX836 with traditional antibody-based flu vaccines … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report by Product (eCOA, CTMS, EDC & CDMS), by Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), by Development Phase, by End Use, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global eClinical solutions market size is expected to reach USD … [Read more…]

LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following a positive review of the safety … [Read more…]

Lab-Quality, Instrument-Free Veros™ COVID-19 Molecular Test Available Now BOSTON & OXFORD, England & CAMBRIDGE, England–(BUSINESS WIRE)–Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Sense’s Veros COVID-19, the first test on the rapid, instrument-free, point-of-care Veros molecular testing platform. The self-contained, … [Read more…]

Aster Guardians Global Nursing Award is one of the world’s top awards in nursing with the highest prize money The first edition was held in Dubai on International Nurses Day in May 2022 which saw Nurse Anna Qabale Duba from Kenya win the award Nurses from around the world can submit their nominations via www.asterguardians.com … [Read more…]

Michel Therin joins as Chairman of the Board of Directors and Mike Lobinsky as Independent Board Member PARIS–(BUSINESS WIRE)–#ft120—Ganymed Robotics, a developer of computer vision algorithms and robotics technologies for orthopedic surgeons, announced it has appointed Michel Therin as Chairman of the Board of Directors and Mike Lobinsky as Independent Board Member. Michel Therin brings … [Read more…]

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Alnylam® Pharmaceuticals (Alnylam), which will enable Alnylam to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a hallmark … [Read more…]

HONG KONG–(BUSINESS WIRE)–Pacific Prime, an award-winning global health insurance brokerage and employee benefits specialist, has released the fifth edition of their annual State of Health Insurance Report. Individual and corporate clients can discover key trends influencing the international private medical insurance (IPMI) sector, such as health inequality, the growth of telemedicine services, the need to … [Read more…]

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States District Court for the District of Delaware issued an opinion in the pending litigation concerning United Therapeutics’ U.S. patents 9,593,066 (the ’066 patent) and 10,716,793 (the ’793 patent). This litigation concerns whether … [Read more…]